Xencor Inc - 8-K Filing
Xencor announces updated Phase 1 study results for XmAb819 and projects cash runway into 2029. (Items: 2.02 Results of Operations and Financial Condition, 7.01 Regulation FD Disclosure, 8.01 Other Events, 9.01 Financial Statements and Exhibits)
Tickers: $XNCR
Read the full article at SEC EDGAR
Part of the story Veradermics, Inc - 8-K Filing (3 articles)